UCLA opens first engineered blood stem cell clinical trial for cancers with the NY-ESO-1 tumor marker


Newswise imageScientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have initiated a phase 1 clinical trial to test a novel cancer treatment for certain kinds of cancers that have a specific tumor marker called NY-ESO-1.